UCHealth Parkview Registered Nurse Elizabeth "Libby" Vogel went the extra mile to help a patient in need and was honored for ...

Rocky Mountain National Park announced April 3 that lab tests conducted by the U.S. Geological Survey confirmed that a fungus has been detected in bats found in the Holzwarth Historic Site area, ...

Aspen Neuroscience, Inc., a private biotechnology company developing personalized, autologous cell therapies, has appointed ...

Aspen Neuroscience scientists, led by Chief Scientific Officer Xiaokui Zhang, Ph.D., will present at the International Society for Gene & Cell Therapy (ISCT) Annual Meeting, held this week May 7-10 at ...

The Centers for Disease Control and Prevention has laid off thousands of workers since January. Current and former CDC staff ...

Aspen Neuroscience has released 6-month data from the first three patients dosed in the ASPIRO Phase 1/2a trial of ANPD001, an investigational autologous dopaminergic neuronal precursor cell (DANPC) ...

The National Institutes of Health will partner with the Centers for Medicare and Medicaid to create a database of Americans ...

Aspen's personalized approach means that patients ... iPSC platform is used to create personalized therapies to address diseases with high unmet medical needs, beginning with autologous neuron ...

For further information, please contact Professor Dr Felix Ringshausen, ringshausen.felix@mh-hannover.de, telephone (0511) 532-3595. The original paper ‘Phase 3 Trial of the DPP1 Inhibitor Brensocatib ...

Insmed invests heavily in a robust pipeline with multi-billion potential, positioning for future growth. Check out why INSM stock is rated buy.

The same dynamic plays out in other genetic conditions. Stunning advances in genetic science have revealed the subtle, insidious culprits behind these brutal diseases and have started paving the way ...

Q1 2025 Earnings Call Transcript May 8, 2025 Insmed Incorporated misses on earnings expectations. Reported EPS is $-1.42 EPS, ...